STAT3 and lung adenocarcinoma: According to our results, overexpressed PRDM5 is likely to upregulate the promoter activity of SOCS1 and further suppress the JAK2/STAT3 pathway by inhibiting the phosphorylation of JAK2 and STAT3, thus repressing cell proliferation in lung adenocarcinoma.